The Oct DNA motif participates in the alcohol inhibition of the inducible nitric oxide synthase gene promoter in rat C6 glioma cells.
Induction of nitric oxide synthase-2 (iNOS) by cytokines and bacterial products is associated with protein binding at the proximal promoter and in an upstream enhancer region of the Nos2 gene. To clarify how ethanol suppresses rat iNOS activity, we constructed several deletion mutants of the Nos2 promoter fused to the luciferase gene and transfected the constructs into C6 glial cells. Acute ethanol exposure of stably transfected cells for 24 h inhibits induced activity of Nos2 promoter constructs containing deletions in the 5' flanking region, including a 94 bp promoter that lacks any known NF-kappaB site but which carries a C/EBPbeta and overlapping gamma-IRE, GAS and Oct motifs. Ethanol failed to inhibit the endogenous activity of a smaller, 78 bp promoter that lacks the C/EBPbeta and overlapping, gamma-IRE and GAS motifs and showed no inducible activity. As another approach, in vivo DNA footprinting was used and identified protein protections at five regions of the proximal Nos2 promoter in induced cells. Exposure to acute ethanol diminished protein occupation in the five promoter regions including the gamma-IRE/NF-kappaB and the overlapping gamma-IRE/GAS/Oct sites. Site-directed mutagenesis in the octamer domain of the gamma-IRE/GAS/Oct motifs was studied in a 1002 bp promoter to examine its role in ethanol inhibition of cytokine and lipopolysaccharide induced activity. The data indicate that ethanol failed to inhibit promoter activity when the Oct motif is missing. Electrophoretic mobility shift assays performed using a 22-mer probe containing the overlapping gamma-IRE/GAS/Oct sites showed three complexes with one of the complexes being competed by an octamer-1 antibody. These observations demonstrate the role of protein-DNA binding at the core promoter, and the likely involvement of the octamer motif, in ethanol modulation of cytokine and lipopolysaccharide induced iNOS expression.
Sanchez
Alma C
AC
Garrison Institute on Aging, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.
Davis
Randall L
RL
Syapin
Peter J
PJ
D000818:Animals; D001932:Brain Neoplasms / Q000378:metabolism*; D045744:Cell Line, Tumor; D002492:Central Nervous System Depressants / Q000494:pharmacology*; D016207:Cytokines / Q000096:biosynthesis; D004247:DNA / Q000502:physiology*; D018983:DNA Footprinting; D024202:Electrophoretic Mobility Shift Assay; D000431:Ethanol / Q000494:pharmacology*; D005786:Gene Expression Regulation / Q000502:physiology; D005910:Glioma / Q000378:metabolism*; D008070:Lipopolysaccharides / Q000633:toxicity; D008156:Luciferases / Q000235:genetics; D009457:Neuroglia / Q000187:drug effects / Q000201:enzymology; D052247:Nitric Oxide Synthase Type II / Q000235:genetics*; D050810:Octamer Transcription Factors / Q000502:physiology*; D010641:Phenotype; D011401:Promoter Regions, Genetic / Q000187:drug effects*; D051381:Rats
D002492:Central Nervous System Depressants; D016207:Cytokines; D008070:Lipopolysaccharides; D050810:Octamer Transcription Factors; D000431:Ethanol; D004247:DNA; D008156:Luciferases; D052247:Nitric Oxide Synthase Type II